Publications
Export 17 results:
Filters: Author is Dupré, Nicolas [Clear All Filters]
“Distinct Plasma Immune Profile in ALS Implicates sTNFR-II in pAMPK/Leptin Homeostasis.”, Int J Mol Sci, vol. 24, no. 6, 2023.
“Association of Essential Tremor With Novel Risk Loci: A Genome-Wide Association Study and Meta-analysis.”, JAMA Neurol, vol. 79, no. 2, pp. 185-193, 2022.
“Goal management training and psychoeducation / mindfulness for treatment of executive dysfunction in Parkinson's disease: A feasibility pilot trial.”, PLoS One, vol. 17, no. 2, p. e0263108, 2022.
“Altered Theory of Mind in Parkinson's Disease and Impact on Caregivers: A Pilot Study.”, Can J Neurol Sci, pp. 1-4, 2021.
, “The Quebec Parkinson Network: A Researcher-Patient Matching Platform and Multimodal Biorepository.”, J Parkinsons Dis, vol. 10, no. 1, pp. 301-313, 2020.
, “Transmission of ALS pathogenesis by the cerebrospinal fluid”, Acta neuropathologica communications, vol. 8, no. 1, pp. 65 - 65, 2020.
, “Transmission of ALS pathogenesis by the cerebrospinal fluid.”, Acta Neuropathol Commun, vol. 8, no. 1, p. 65, 2020.
, “Portrait of blood-derived extracellular vesicles in patients with Parkinson's disease.”, Neurobiol Dis, vol. 124, pp. 163-175, 2019.
, “Effects of Antiparkinson Medication on Cognition in Parkinson's Disease: A Systematic Review.”, Can J Neurol Sci, vol. 45, no. 4, pp. 375-404, 2018.
, “Goal management training ® home-based approach for mild cognitive impairment in Parkinson's disease: a multiple baseline case report.”, Neurocase, vol. 24, no. 5-6, pp. 276-286, 2018.
, “The influence of vascular risk factors on cognitive function in early Parkinson's disease.”, Int J Geriatr Psychiatry, vol. 33, no. 2, pp. 288-297, 2018.
, “Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis.”, Sci Rep, vol. 8, no. 1, p. 14223, 2018.
, “Smoking history is associated to cognitive impairment in Parkinson's disease.”, Aging Ment Health, vol. 21, no. 3, pp. 322-326, 2017.
, “From animal models to human disease: a genetic approach for personalized medicine in ALS.”, Acta Neuropathol Commun, vol. 4, no. 1, p. 70, 2016.
, “Biophysical characterization of M1476I, a sodium channel founder mutation associated with cold-induced myotonia in French Canadians.”, J Physiol, vol. 590, no. 11, pp. 2629-44, 2012.
, “Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB-mediated pathogenic pathways.”, J Exp Med, vol. 208, no. 12, pp. 2429-47, 2011.
, “Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis.”, Proc Natl Acad Sci U S A, vol. 106, no. 51, pp. 21777-82, 2009.
,